Mindfulness meditation and the immune system: a systematic review of randomized controlled trials

Annals of the New York Academy of Sciences

Volumn 1373, Issue 1, 2016, Pages 13-24

  Black, David S ^a   Slavich, George M ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; biology; cytokines; disease; health; immune system; inflammation; intervention; meditation; mindfulness

Indexed keywords

C REACTIVE PROTEIN; TRANSCRIPTION FACTOR;

AGING; ANTIBODY RESPONSE; ARTICLE; AWARENESS; CELLULAR IMMUNITY; COMPARATIVE STUDY; GENE EXPRESSION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MEDITATION; MINDFULNESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLING; SYSTEMATIC REVIEW;

EID: 84979519053     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12998     Document Type: Article

References (75)

1. Kabat-Zinn, J. 2003. Mindfulness-based interventions in context: past, present, and future. Clin. Psychol. Sci. Pract. 10: 144–156.
2. Black, D.S. 2014. Mindfulness-based interventions: an antidote to suffering in the context of substance use, misuse, and addiction. Subst. Use Misuse 49: 487–491.
3. Rapgay, L. & A. Bystrisky. 2009. Classical mindfulness: an introduction to its theory and practice for clinical application. Ann. N.Y. Acad. Sci. 1172: 148–162.
4. Buchholz, L. 2015. Exploring the promise of mindfulness as medicine. JAMA 314: 1327–1329.
5. Goyal, M., S. Singh, E.M. Sibinga, et al. 2014. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern. Med. 174: 357–368.
6. O'Reilly, G.A., L. Cook, D. Spruijt-Metz & D.S. Black. 2014. Mindfulness-based interventions for obesity-related eating behaviours: a literature review. Obes. Rev. 15: 453–461.
7. Black, D.S., J. Milam & S. Sussman. 2009. Sitting-meditation interventions among youth: a review of treatment efficacy. Pediatrics 124: 532–541.
8. Grossman, P., L. Niemann, S. Schmidt & H. Walach. 2004. Mindfulness-based stress reduction and health benefits. A meta-analysis. J. Psychosom. Res. 57: 35–43.
9. Hofmann, S.G., A.T. Sawyer, A.A. Witt & D. Oh. 2010. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J. Consult. Clin. Psychol. 78: 169–183.
10. Goyal, M., S. Singh, E.M.S. Sibinga, et al. 2014. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern. Med. 174: 357–368.
11. Black, D.S. & J. Greeson. 2014. Mindfulness-based interventions in routine clinical care for stress-related ailments: comment. JAMA Intern. Med. 174: 357–368.
12. Black, D.S., G.A. O'Reilly, R. Olmstead, et al. 2015. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Intern. Med. 175: 494–501.
13. Bowen, S., K. Witkiewitz, S.L. Clifasefi, et al. 2014. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry 71: 547–556.
14. Krasner, M.S., R.M. Epstein, H. Beckman, et al. 2009. Association of an educational program in mindful communication with burnout, empathy, and attitudes among primary care physicians. JAMA 302: 1284–1293.
15. Kuyken, W., R. Hayes, B. Barrett, et al. 2015. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 386: 63–73.
16. Haas, L., M. Maryniuk, J. Beck, et al. 2013. National standards for diabetes self-management education and support. Diabetes Care 36(Suppl. 1): S100–S108.
17. Ford, E.S., M.M. Bergmann, H. Boeing, et al. 2012. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev. Med. 55: 23–27.
18. Galla, B.M., G.A. O'Reilly, M.J. Kitil, et al. 2015. Community-based mindfulness program for disease prevention and health promotion: targeting stress reduction. Am. J. Health Promot. 30: 36–41.
19. Greeson, J.M., E.L. Garland & D.S. Black. 2014. “Mindfulness: a transtherapeutic approach for transdiagnostic mental processes.” In The Wiley Blackwell Handbook of Mindfulness, Vol. II. A. Ie, C. Ngnoumen & E. Langer, Eds.: 533–562. Oxford: Wiley.
20. Khoury, B., T. Lecomte, G. Fortin, et al. 2013. Mindfulness-based therapy: a comprehensive meta-analysis. Clin. Psychol. Rev. 33: 763–771.
21. Creswell, J.D. & E.K. Lindsay. 2014. How does mindfulness training affect health? A mindfulness stress buffering account. Curr. Dir. Psychol. Sci. 23: 401–407.
22. Slavich, G.M. 2015. Understanding inflammation, its regulation, and relevance for health: a top scientific and public priority. Brain Behav. Immun. 45: 13–14.
23. Couzin-Frankel, J. 2010. Inflammation bares a dark side. Science 330: 1621.
24. Barrett, B., M.S. Hayney, D. Muller, et al. 2012. Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial. Ann. Fam. Med. 10: 337–346.
25. Rosenkranz, M.A., R.J. Davidson, D.G. Maccoon, et al. 2013. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav. Immun. 27: 174–184.
26. Carlson, L.E., M. Speca, K.D. Patel & E. Goodey. 2003. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom. Med. 65: 571–581.
27. Carlson, L.E., M. Speca, P. Faris & K.D. Patel. 2007. One year pre–post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav. Immun. 21: 1038–1049.
28. Gallegos, A.M., M.C. Lytle, J.A. Moynihan & N.L. Talbot. 2015. Mindfulness-based stress reduction to enhance psychological functioning and improve inflammatory biomarkers in trauma-exposed women: a pilot study. Psychol. Trauma 7: 525–532.
29. Hoge, E.A., M.M. Chen, E. Orr, et al. 2013. Loving-kindness meditation practice associated with longer telomeres in women. Brain Behav. Immun. 32: 159–163.
30. Kaliman, P., M.J. Alvarez-Lopez, M. Cosin-Tomas, et al. 2014. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology 40: 96–107.
31. Lengacher, C.A., K.E. Kip, M.K. Barta, et al. 2012. A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J. Holist. Nurs. 30: 170–185.
32. Robinson, F.P., H.L. Mathews & L. Witek-Janusek. 2003. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J. Altern. Complement. Med. 9: 683–694.
33. Witek-Janusek, L., K. Albuquerque, K.R. Chroniak, et al. 2008. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav. Immun. 22: 969–981.
34. van Genderen, M.E., A. Lima, H. de Geus, et al. 2011. Serum C-reactive protein as a predictor of morbidity and mortality in intensive care unit patients after esophagectomy. Ann. Thorac. Surg. 91: 1775–1779.
35. Carlstedt, F., L. Lind & B. Lindahl. 1997. Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J. Intern. Med. 242: 361–365.
36. Celli, B.R., N. Locantore, J. Yates, et al. 2012. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185: 1065–1072.
37. Bower, J.E., A.D. Crosswell, A.L. Stanton, et al. 2015. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer 121: 1231–1240.
38. Creswell, J.D., M.R. Irwin, L.J. Burklund, et al. 2012. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav. Immun. 26: 1095–1101.
39. Jedel, S., A. Hoffman, P. Merriman, et al. 2014. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion 89: 142–155.
40. Malarkey, W.B., D. Jarjoura & M. Klatt. 2013. Workplace based mindfulness practice and inflammation: a randomized trial. Brain Behav. Immun. 27: 145–154.
41. Oken, B.S., I. Fonareva, M. Haas, et al. 2010. Pilot controlled trial of mindfulness meditation and education for dementia caregivers. J. Altern. Complement. Med. 16: 1031–1038.
42. Zautra, A.J., M.C. Davis, J.W. Reich, et al. 2008. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J. Consult. Clin. Psychol. 76: 408–421.
43. Elsenbruch, S., J. Langhorst, K. Popkirowa, et al. 2005. Effects of mind–body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother. Psychosom. 74: 277–287.
44. Hayney, M.S., C.L. Coe, D. Muller, et al. 2014. Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial. Hum. Vaccin. Immunother. 10: 83–91.
45. Lengacher, C.A., K.E. Kip, J. Post-White, et al. 2013. Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy. Biol. Res. Nurs. 15: 37–47.
46. Fogarty, F.A., R.J. Booth, G.D. Gamble, et al. 2015. The effect of mindfulness-based stress reduction on disease activity in people with rheumatoid arthritis: a randomised controlled trial. Ann. Rheum. Dis. 74: 472–474.
47. Slavich, G.M. & S.W. Cole. 2013. The emerging field of human social genomics. Clin. Psychol. Sci. 1: 331–348.
48. Bharti, A.C. & B.B. Aggarwal. 2002. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64: 883–888.
49. Rohleder, N. 2014. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom. Med. 76: 181–189.
50. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431–436.
51. Irwin, M.R. & S.W. Cole. 2011. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11: 625–632.
52. Slavich, G.M. & M.R. Irwin. 2014. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol. Bull. 140: 774–815.
53. Pace, T.W., T.C. Mletzko, O. Alagbe, et al. 2006. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163: 1630–1633.
54. Bierhaus, A., J. Wolf, M. Andrassy, et al. 2003. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U.S.A. 100: 1920–1925.
55. Murphy, M.L., G.M. Slavich, N. Rohleder, et al. 2013. Targeted rejection triggers differential pro- and anti-inflammatory gene expression in adolescents as a function of social status. Clin. Psychol. Sci. 1: 30–40.
56. Black, D.S., G.A. O'Reilly, R. Olmstead, et al. 2015. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Intern. Med. 175: 494–501.
57. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126: 946–954.
58. Reiche, E.M., S.O. Nunes & H.K. Morimoto. 2004. Stress, depression, the immune system, and cancer. Lancet Oncol. 5: 617–625.
59. + T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav. Immun. 23: 184–188.
60. Gonzalez-Garcia, M., M.J. Ferrer, X. Borras, et al. 2014. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 18: 676–685.
61. SeyedAlinaghi, S., S. Jam, M. Foroughi, et al. 2012. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4(+) T lymphocyte count and medical and psychological symptoms. Psychosom. Med. 74: 620–627.
62. Gonzalez-Garcia, M., M.J. Ferrer, X. Borras, et al. 2013. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 18: 676–685.
63. Blackburn, E.H. 1991. Structure and function of telomeres. Nature 350: 569–573.
64. Cawthon, R.M., K.R. Smith, E. O'Brien, et al. 2003. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361: 393–395.
65. Carlson, L.E., T.L. Beattie, J. Giese-Davis, et al. 2015. Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors. Cancer 121: 476–484.
66. Lengacher, C.A., R.R. Reich, K.E. Kip, et al. 2014. Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC). Biol. Res. Nurs. 16: 438–447.
67. Daubenmier, J., J. Lin, E. Blackburn, et al. 2012. Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study. Psychoneuroendocrinology 37: 917–928.
68. Jacobs, T.L., E.S. Epel, J. Lin, et al. 2011. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 36: 664–681.
69. Kroon, F.P., J.T. van Dissel, J.C. de Jong, et al. 2000. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 18: 3040–3049.
70. Cohen, S., G.E. Miller & B.S. Rabin. 2001. Psychological stress and antibody response to immunization: a critical review of the human literature. Psychosom. Med. 63: 7–18.
71. Kumar, R. & E.A. Burns. 2008. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev. Vaccines 7: 467–479.
72. Moynihan, J.A., B.P. Chapman, R. Klorman, et al. 2013. Mindfulness-based stress reduction for older adults: effects on executive function, frontal alpha asymmetry and immune function. Neuropsychobiology 68: 34–43.
73. Davidson, R.J., J. Kabat-Zinn, J. Schumacher, et al. 2003. Alterations in brain and immune function produced by mindfulness meditation. Psychosom. Med. 65: 564–570.
74. MacCoon, D.G., Z.E. Imel, M.A. Rosenkranz, et al. 2012. The validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR). Behav. Res. Ther. 50: 3–12.
75. Black, D.S., G.A. O'Reilly, R. Olmstead, et al. 2014. Mindfulness-based intervention for prodromal sleep disturbances in older adults: design and methodology of a randomized controlled trial. Contemp. Clin. Trials 39: 22–27.